Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice

被引:88
作者
Egashira, N
Hayakawa, K
Mishima, K
Kimura, H
Iwasaki, K
Fujiwara, M
机构
[1] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Adv Mat Inst, Fukuoka 8140180, Japan
关键词
gamma-glutamylethylamide; theanine; focal cerebral ischemia; neuroprotection; middle cerebral artery;
D O I
10.1016/j.neulet.2004.03.046
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the present study, we examined the neuroprotective effect of gamma-glutamylethylamide (theanine) on the ischemic brain damage in a middle cerebral artery occlusion model in mice. Theanine was injected i.p. 3 h after the occlusion or immediately before and 3 h after the occlusion. Theanine (1 mg/kg) significantly decreased the size of the cerebral infarcts 1 day after the occlusion. In contrast, theanine did not affect the cerebral blood flow, brain temperature and physiological variables (pH, pCO(2), pO(2) and hematocrit) in this model. These results suggest that theanine directly provides neuroprotection against focal cerebral ischemia and may be clinically useful for preventing cerebral infarction. (C) 2004 Published by Elsevier Ireland Ltd.
引用
收藏
页码:58 / 61
页数:4
相关论文
共 20 条
  • [1] Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia
    Arias, RL
    Tasse, JRP
    Bowlby, MR
    [J]. BRAIN RESEARCH, 1999, 816 (02) : 299 - 308
  • [2] THE EFFECT OF THE NMDA RECEPTOR ANTAGONIST MK-801 ON CEREBRAL BLOOD-FLOW AND INFARCT VOLUME IN EXPERIMENTAL FOCAL STROKE
    BUCHAN, AM
    SLIVKA, A
    XUE, D
    [J]. BRAIN RESEARCH, 1992, 574 (1-2) : 171 - 177
  • [3] AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats
    Hiroshi, Y
    Ibayashi, S
    Nakane, H
    Cai, H
    Uchimura, H
    Fujishima, M
    [J]. BRAIN RESEARCH, 1997, 753 (01) : 80 - 85
  • [4] Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats
    Iwasaki, K
    Chung, EH
    Egashira, E
    Hatip-Al-Khatib, I
    Mishima, K
    Egawa, T
    Irie, K
    Fujiwara, M
    [J]. BRAIN RESEARCH, 2004, 995 (01) : 131 - 139
  • [5] YM90K, AN AMPA ANTAGONIST, HAS NO NEUROTOXIC EFFECTS ON CEREBROCORTICAL NEURONS IN RATS
    IZUMISAWA, N
    KAWAKAMI, A
    OHATA, T
    HANADA, T
    OKEDA, R
    [J]. EXPERIMENTAL NEUROLOGY, 1995, 134 (02) : 199 - 204
  • [6] Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors
    Kakuda, T
    Nozawa, A
    Sugimoto, A
    Niino, H
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2002, 66 (12) : 2683 - 2686
  • [7] Protective effect of γ-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils
    Kakuda, T
    Yanase, H
    Utsunomiya, K
    Nozawa, A
    Unno, T
    Kataoka, K
    [J]. NEUROSCIENCE LETTERS, 2000, 289 (03) : 189 - 192
  • [8] YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats
    Kawasaki-Yatsugi, S
    Ichiki, C
    Yatsugi, S
    Shimizu-Sasamata, M
    Yamaguchi, T
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (05) : 586 - 591
  • [9] Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats
    KawasakiYatsugi, S
    Yatsugi, S
    Koshiya, K
    ShimizuSasamata, M
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 74 (03) : 253 - 260
  • [10] KIMURA R, 1971, CHEM PHARM BULL, V19, P1257